| How much data should we collect in a randomized clinical trial? | |
| | |
MedLine Citation:
|
PMID: 2189185 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Multicentre randomized controlled clinical trials are usually designed to answer a specific question. In accomplishing this they often collect a large quantity of data during screening, baseline and follow-up visits. These data are not all necessarily related to the main study question. This collection impacts on the overall recruitment process and the participants' time. During the planning phase of the trial we need to consider the reasons for collecting data and the use of that data for the current study as well as its potential use in future investigations. We discuss briefly some of the possible reasons that data may be collected: screening or determining eligibility; conducting a run-in or dose titration phase; assessing group comparability; aiding patient management; evaluating the natural history of the disease; monitoring the study; testing the study hypotheses; evaluating adherence; estimating side effects and the use of other therapies; analysis of other study questions. |
| | |
Authors:
|
J Verter |
Related Documents
:
|
17591655 - Pharmacological models in healthy volunteers: their use in the clinical development of ... 7973215 - Interim analysis: the alpha spending function approach. 7018605 - A bayesian approach to bioequivalence for the 2 x 2 changeover design. 8089035 - Analysis of single trial movement-related brain macropotential. 459965 - Gastric cancer etiology: a biochemical hypothesis. 22891065 - Act together-implications of symbioses in aquatic ciliates. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study |
Journal Detail:
|
Title: Statistics in medicine Volume: 9 ISSN: 0277-6715 ISO Abbreviation: Stat Med Publication Date: 1990 Jan-Feb |
Date Detail:
|
Created Date: 1990-06-29 Completed Date: 1990-06-29 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8215016 Medline TA: Stat Med Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 103-11; discussion 112-3 Citation Subset: IM |
Affiliation:
|
Biostatistics Research Branch, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Data Collection
/
methods* Drug Therapy / adverse effects Humans Multicenter Studies as Topic Patient Compliance Quality Control Randomized Controlled Trials as Topic / methods* Time Factors |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Diagnosis of myasthenia gravis in the 1990s.
Next Document: An evaluation of central laboratories in three VA cooperative studies.